摘要
目的观察支气管动脉栓塞术治疗肺癌大出血的临床效果及安全性。方法收取2012年8月至2013年2月在我院肿瘤科住院治疗的68例支气管肺癌大出血患者,采取随机原则和双盲原则将其分成两组,对照组接受垂体后叶素治疗,治疗组接受支气管动脉栓塞术治疗,分析比较两组的治疗效果。结果治疗组的总有效率高于对照组(P=0.003);治疗组与对照组治疗后的不良反应相互比较,差异无统计学意义(P=0.33)。结论支气管动脉栓塞术治疗支气管肺癌大出血安全可靠,疗效优于垂体后叶素,值得临床推广。
Objective To explore the chnical effect of bronchial artery embolization(BAE) in treating massive haemorrhage caused by lung cancer. Methods Between August 2010 and Feb 2013, 68 patients who accepted treatment in our hospital were divided randomly and double-blindly into two groups. The control group was treated with Pituitrin, while the treating group was operated with BAE. The clinical effect were analyzed and compared between the two groups. Results After treatment, the total effective rate in the treating group is higher than in the control group, with significantly statistical difference (P=0.003). There was no statistical difference in the side effects between the treating group and control group (P = 0.33). Conclusion The bronchial artery embolization had better clinical effect than Pituitrin in treating massive haemorrhage caused by lung cancer. It deserves wide application in clinics..
出处
《肿瘤药学》
CAS
2013年第3期216-218,226,共4页
Anti-Tumor Pharmacy
基金
湖南省医药卫生科研计划项目(编号:B2012-098)
湖南省科技厅科技计划项目(编号:2009SK3109)
关键词
支气管动脉栓塞术
支气管肺癌
临床疗效
BAE
Bronchogenic carcinoma
Massive haemorrhage
Clinical effect